Ubs Asset Management Americas Inc Horizon Therapeutics Public LTD CO Transaction History

Ubs Asset Management Americas Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $8.27 Million - $9.67 Million	83,525 Added 8.13%	1,111,231 $129 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $2.2 Million - $2.32 Million	20,476 Added 2.03%	1,027,706 $112 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $1.39 Million - $2.53 Million	22,248 Added 2.26%	1,007,230 $115 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $58 Million - $83.4 Million	984,982 New	984,982 $61 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.